Analysis of Prescription Drug Utilization with Beta Regression Models
Guojun Gan and
Emiliano A. Valdez
North American Actuarial Journal, 2022, vol. 26, issue 2, 205-226
Abstract:
The health care sector in the United States is complex and is also a large sector that generates about 20% of the country’s gross domestic product. Health care analytics has been used by researchers and practitioners to better understand the industry. In this article, we examine and demonstrate the use of Beta regression models to study the utilization of brand name drugs in the United States to understand the variability of brand name drug utilization across different areas. The models are fitted to public datasets obtained from the Medicare & Medicaid Services and the Internal Revenue Service. Integrated nested Laplace approximation (INLA) is used to perform the inference. The numerical results show that Beta regression models can fit the brand name drug claim rates well and including spatial dependence improves the performance of the Beta regression models. Such models can be used to reflect the effect of prescription drug utilization when updating an insured’s health risk in a risk scoring model.
Date: 2022
References: Add references at CitEc
Citations:
Downloads: (external link)
http://hdl.handle.net/10.1080/10920277.2021.1890127 (text/html)
Access to full text is restricted to subscribers.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:taf:uaajxx:v:26:y:2022:i:2:p:205-226
Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/uaaj20
DOI: 10.1080/10920277.2021.1890127
Access Statistics for this article
North American Actuarial Journal is currently edited by Kathryn Baker
More articles in North American Actuarial Journal from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().